Purchase Order W81K0018P0590
Award Date
10/1/18
Potential Completion Date
9/30/23
Potential Value
$480K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Immucor Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Norcross, GA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Immucor Inc. for the delivery of two Blood Bank Automated Analyzers to support the Pathology Department at William Beaumont Army Medical Center (WBAMC) in Fort Bliss, Texas. The contract has a total ceiling value of $535,165.00 and a period of performance from October 1, 2023 to September 30, 2028. Immucor, a manufacturer of in vitro diagnostic equipment and reagents for blood transfusion and transplantation, was...
This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products, specifically blood typing, compatibility testing, and antibody screening reagents and consumables. The $137,483.05 contract has an ultimate completion date of December 31, 2027 and does not utilize any set-aside designations. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare...
This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...
This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) component of the Department of Defense to Immucor Inc., a manufacturer of in vitro diagnostic products and reagents. The $187,452.19 contract is for the delivery of molecular BeadChip reagents compatible with the BioArray Array Imaging System (AIS 400) and BioArray Solutions Information System Software (BASIS) to support blood typing and screening operations at the Brooke Army Medical Center in Fort Sam...
This is a $61,238.20 firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Immucor Inc. for the delivery of blood bank reagents. The contract has an ultimate completion date of October 1, 2027. Immucor, a manufacturer of in vitro diagnostic products for transfusion and transplantation testing, was awarded this sole source contract under FAR 13.106-1 based on its specialized capabilities and proprietary solutions. The contract is not associated with a federal...
This federal contract was awarded by the Department of Health and Human Services Indian Health Service to Immucor Inc., a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation compatibility testing. The $114,896.73 firm fixed-price purchase order is for a "BLOOD SYSTEM AND SUPPORT SERVICE" to be performed in Phoenix, Arizona. The contract has a completion date of September 30, 2023 and was originally awarded on August 29,...
This is a $75,528.60 firm-fixed-price purchase order contract awarded by the U.S. Air Force's Air Combat Command to Immucor Inc., a for-profit manufacturer, on December 31, 2021. The contract is for the provision of blood bank reagents to support blood typing, compatibility testing, and other critical blood banking operations at Nellis Air Force Base in Nevada. It has a period of performance through September 30, 2025. The contract was set aside for small businesses. Immucor is an experienced...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer, for the delivery of medical supplies such as fetal blood screen kits, blood cells, and PanoCell products. The potential value of the contract is $216,898.69, with a performance period through April 24, 2023. The contract does not have a set-aside designation. Immucor has previously been awarded federal contracts to provide blood banking supplies, reagents, and testing...
This is a $4,970.47 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The contract provides Immucor's specialized reagents, blood analyzers, testing equipment, and related consumables to support blood typing, compatibility testing, antibody screening, and critical blood banking operations within federal health networks and military treatment centers. Immucor has a...